Douglas Research Insights

Douglas Research Insights

Share this post

Douglas Research Insights
Douglas Research Insights
Orum Therapeutics Lowers IPO Price Range
Copy link
Facebook
Email
Notes
More

Orum Therapeutics Lowers IPO Price Range

Douglas Kim's avatar
Douglas Kim
Jan 03, 2025
∙ Paid

Share this post

Douglas Research Insights
Douglas Research Insights
Orum Therapeutics Lowers IPO Price Range
Copy link
Facebook
Email
Notes
More
1
Share
  • Orum Therapeutics (475830 KS) has lowered its IPO price range to 24,000 won to 30,000 won.

  • The IPO offering amount will be between 60 billion won to 75 billion won. The expected market cap of the IPO is between 531 billion won to 664 billion won.

  • Our updated valuation of Orum Therapeutics suggests implied target price of 24,939 won per share, which is 8% lower than the mid-point of the revised down IPO price range.

Keep reading with a 7-day free trial

Subscribe to Douglas Research Insights to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Douglas Kim
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More